Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. (Q42719368)
Jump to navigation
Jump to search
scientific article published on September 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. |
scientific article published on September 2011 |
Statements
Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus (English)
Mario Furlanut
J M Entenza
T R Veloso
J Vouillamoz
M Giddey
P Moreillon
1 September 2011
4496; author reply 4496-7